Systematic review on the compliance of WHO guidelines in the management of patients with advanced HIV disease in Africa: The case of cryptococcal antigen screening.

<h4>Background</h4>The World Health Organization (WHO) recommended cryptococcal antigen (CrAg) screening for people presenting with advanced HIV disease (AHD) and for those with positive CrAg without evidence of meningitis to initiate preemptive antifungal medication. Data on the impleme...

Full description

Saved in:
Bibliographic Details
Main Authors: Zuhura Mbwana Ally, Jackline Vicent Mbishi, Mariam Salim Mbwana, Hafidha Mhando Bakari, Swalehe Mustafa Salim, Zarin Nudar Rodoshi, Muhidin Ibrahim Hundisa, Rebecca Mesfin Sileshi, Biruk Demisse Ayalew, Rahma Musoke, Lynn Moshi, Yousef Elias Fakhoury, Haji Mbwana Ally, Habib Omari Ramadhani
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2025-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0313453
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832540171470372864
author Zuhura Mbwana Ally
Jackline Vicent Mbishi
Mariam Salim Mbwana
Hafidha Mhando Bakari
Swalehe Mustafa Salim
Zarin Nudar Rodoshi
Muhidin Ibrahim Hundisa
Rebecca Mesfin Sileshi
Biruk Demisse Ayalew
Rahma Musoke
Lynn Moshi
Yousef Elias Fakhoury
Haji Mbwana Ally
Habib Omari Ramadhani
author_facet Zuhura Mbwana Ally
Jackline Vicent Mbishi
Mariam Salim Mbwana
Hafidha Mhando Bakari
Swalehe Mustafa Salim
Zarin Nudar Rodoshi
Muhidin Ibrahim Hundisa
Rebecca Mesfin Sileshi
Biruk Demisse Ayalew
Rahma Musoke
Lynn Moshi
Yousef Elias Fakhoury
Haji Mbwana Ally
Habib Omari Ramadhani
author_sort Zuhura Mbwana Ally
collection DOAJ
description <h4>Background</h4>The World Health Organization (WHO) recommended cryptococcal antigen (CrAg) screening for people presenting with advanced HIV disease (AHD) and for those with positive CrAg without evidence of meningitis to initiate preemptive antifungal medication. Data on the implementation of WHO recommendations regarding CrAg screening is limited. We estimated pooled prevalence of CrAg screening uptake, cryptococcal antigenemia, lumbar puncture, cryptococcal meningitis and initiation of preemptive antifungal medication from available eligible published studies conducted in Africa.<h4>Methods</h4>PubMed, Cochrane Library and Embase were searched for articles published between January 2011 and December 2023. CrAg uptake was defined as percentage of eligible people (CD4 ≤ 200 cells/mm3 or WHO stage III/IV) who received cryptococcal antigen testing. Stratified analysis to compare uptake and cryptococcal antigenemia between studies that involved multiple vs single sites was performed. Using random effects models, we computed the pooled estimate of CrAg screening uptake, cryptococcal antigenemia, lumbar puncture, cryptococcal meningitis, preemptive antifungals treatment and 95% confidence intervals (CIs).<h4>Results</h4>Ten studies with 18,820 individuals with AHD were analyzed. Overall, the pooled estimate of CrAg screening uptake was 57.1% (95% CI: 41.4-72.7). CrAg screening uptake was significantly lower among studies that involved multiple sites compared to those that involved single site, (47.3% vs 73.3%; p<0.001). Overall, the pooled prevalence of cryptococcal antigenemia was 9.6% (95% CI:6.4-12.9). Cryptococcal antigenemia was significantly lower among studies that involved multiple sites compared to those that involved single site, (9.1% vs 10.4%; p<0.001). Among those who tested positive for CrAg, 84.6% (95% CI: 54.1-99.0) received preemptive antifungal treatment, though nearly 25% did not undergo lumbar puncture, highlighting gaps in diagnostic follow-up. Six studies evaluated CrAg positive patients with lumbar puncture and the overall prevalence of lumbar puncture was 74.9% (48.0-94.8). The overall prevalence of cryptococcal meningitis was 58.1% (46.6-69.6).<h4>Conclusions</h4>Not screening for CrAg among people with AHD and failure to initiate antifungal medications among eligible patients with cryptococcal antigenemia presents a significant missed opportunity. Emphasis on improving CrAg screening is critical given its proven cost-effective benefits.
format Article
id doaj-art-3b6debb649c44a1dab02b48f16f8ae83
institution Kabale University
issn 1932-6203
language English
publishDate 2025-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj-art-3b6debb649c44a1dab02b48f16f8ae832025-02-05T05:32:12ZengPublic Library of Science (PLoS)PLoS ONE1932-62032025-01-01201e031345310.1371/journal.pone.0313453Systematic review on the compliance of WHO guidelines in the management of patients with advanced HIV disease in Africa: The case of cryptococcal antigen screening.Zuhura Mbwana AllyJackline Vicent MbishiMariam Salim MbwanaHafidha Mhando BakariSwalehe Mustafa SalimZarin Nudar RodoshiMuhidin Ibrahim HundisaRebecca Mesfin SileshiBiruk Demisse AyalewRahma MusokeLynn MoshiYousef Elias FakhouryHaji Mbwana AllyHabib Omari Ramadhani<h4>Background</h4>The World Health Organization (WHO) recommended cryptococcal antigen (CrAg) screening for people presenting with advanced HIV disease (AHD) and for those with positive CrAg without evidence of meningitis to initiate preemptive antifungal medication. Data on the implementation of WHO recommendations regarding CrAg screening is limited. We estimated pooled prevalence of CrAg screening uptake, cryptococcal antigenemia, lumbar puncture, cryptococcal meningitis and initiation of preemptive antifungal medication from available eligible published studies conducted in Africa.<h4>Methods</h4>PubMed, Cochrane Library and Embase were searched for articles published between January 2011 and December 2023. CrAg uptake was defined as percentage of eligible people (CD4 ≤ 200 cells/mm3 or WHO stage III/IV) who received cryptococcal antigen testing. Stratified analysis to compare uptake and cryptococcal antigenemia between studies that involved multiple vs single sites was performed. Using random effects models, we computed the pooled estimate of CrAg screening uptake, cryptococcal antigenemia, lumbar puncture, cryptococcal meningitis, preemptive antifungals treatment and 95% confidence intervals (CIs).<h4>Results</h4>Ten studies with 18,820 individuals with AHD were analyzed. Overall, the pooled estimate of CrAg screening uptake was 57.1% (95% CI: 41.4-72.7). CrAg screening uptake was significantly lower among studies that involved multiple sites compared to those that involved single site, (47.3% vs 73.3%; p<0.001). Overall, the pooled prevalence of cryptococcal antigenemia was 9.6% (95% CI:6.4-12.9). Cryptococcal antigenemia was significantly lower among studies that involved multiple sites compared to those that involved single site, (9.1% vs 10.4%; p<0.001). Among those who tested positive for CrAg, 84.6% (95% CI: 54.1-99.0) received preemptive antifungal treatment, though nearly 25% did not undergo lumbar puncture, highlighting gaps in diagnostic follow-up. Six studies evaluated CrAg positive patients with lumbar puncture and the overall prevalence of lumbar puncture was 74.9% (48.0-94.8). The overall prevalence of cryptococcal meningitis was 58.1% (46.6-69.6).<h4>Conclusions</h4>Not screening for CrAg among people with AHD and failure to initiate antifungal medications among eligible patients with cryptococcal antigenemia presents a significant missed opportunity. Emphasis on improving CrAg screening is critical given its proven cost-effective benefits.https://doi.org/10.1371/journal.pone.0313453
spellingShingle Zuhura Mbwana Ally
Jackline Vicent Mbishi
Mariam Salim Mbwana
Hafidha Mhando Bakari
Swalehe Mustafa Salim
Zarin Nudar Rodoshi
Muhidin Ibrahim Hundisa
Rebecca Mesfin Sileshi
Biruk Demisse Ayalew
Rahma Musoke
Lynn Moshi
Yousef Elias Fakhoury
Haji Mbwana Ally
Habib Omari Ramadhani
Systematic review on the compliance of WHO guidelines in the management of patients with advanced HIV disease in Africa: The case of cryptococcal antigen screening.
PLoS ONE
title Systematic review on the compliance of WHO guidelines in the management of patients with advanced HIV disease in Africa: The case of cryptococcal antigen screening.
title_full Systematic review on the compliance of WHO guidelines in the management of patients with advanced HIV disease in Africa: The case of cryptococcal antigen screening.
title_fullStr Systematic review on the compliance of WHO guidelines in the management of patients with advanced HIV disease in Africa: The case of cryptococcal antigen screening.
title_full_unstemmed Systematic review on the compliance of WHO guidelines in the management of patients with advanced HIV disease in Africa: The case of cryptococcal antigen screening.
title_short Systematic review on the compliance of WHO guidelines in the management of patients with advanced HIV disease in Africa: The case of cryptococcal antigen screening.
title_sort systematic review on the compliance of who guidelines in the management of patients with advanced hiv disease in africa the case of cryptococcal antigen screening
url https://doi.org/10.1371/journal.pone.0313453
work_keys_str_mv AT zuhurambwanaally systematicreviewonthecomplianceofwhoguidelinesinthemanagementofpatientswithadvancedhivdiseaseinafricathecaseofcryptococcalantigenscreening
AT jacklinevicentmbishi systematicreviewonthecomplianceofwhoguidelinesinthemanagementofpatientswithadvancedhivdiseaseinafricathecaseofcryptococcalantigenscreening
AT mariamsalimmbwana systematicreviewonthecomplianceofwhoguidelinesinthemanagementofpatientswithadvancedhivdiseaseinafricathecaseofcryptococcalantigenscreening
AT hafidhamhandobakari systematicreviewonthecomplianceofwhoguidelinesinthemanagementofpatientswithadvancedhivdiseaseinafricathecaseofcryptococcalantigenscreening
AT swalehemustafasalim systematicreviewonthecomplianceofwhoguidelinesinthemanagementofpatientswithadvancedhivdiseaseinafricathecaseofcryptococcalantigenscreening
AT zarinnudarrodoshi systematicreviewonthecomplianceofwhoguidelinesinthemanagementofpatientswithadvancedhivdiseaseinafricathecaseofcryptococcalantigenscreening
AT muhidinibrahimhundisa systematicreviewonthecomplianceofwhoguidelinesinthemanagementofpatientswithadvancedhivdiseaseinafricathecaseofcryptococcalantigenscreening
AT rebeccamesfinsileshi systematicreviewonthecomplianceofwhoguidelinesinthemanagementofpatientswithadvancedhivdiseaseinafricathecaseofcryptococcalantigenscreening
AT birukdemisseayalew systematicreviewonthecomplianceofwhoguidelinesinthemanagementofpatientswithadvancedhivdiseaseinafricathecaseofcryptococcalantigenscreening
AT rahmamusoke systematicreviewonthecomplianceofwhoguidelinesinthemanagementofpatientswithadvancedhivdiseaseinafricathecaseofcryptococcalantigenscreening
AT lynnmoshi systematicreviewonthecomplianceofwhoguidelinesinthemanagementofpatientswithadvancedhivdiseaseinafricathecaseofcryptococcalantigenscreening
AT yousefeliasfakhoury systematicreviewonthecomplianceofwhoguidelinesinthemanagementofpatientswithadvancedhivdiseaseinafricathecaseofcryptococcalantigenscreening
AT hajimbwanaally systematicreviewonthecomplianceofwhoguidelinesinthemanagementofpatientswithadvancedhivdiseaseinafricathecaseofcryptococcalantigenscreening
AT habibomariramadhani systematicreviewonthecomplianceofwhoguidelinesinthemanagementofpatientswithadvancedhivdiseaseinafricathecaseofcryptococcalantigenscreening